Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience (original) (raw)

Management of hepatocellular carcinoma: a study on 240 patients in a single referral center

Iskren Kotzev

Scripta Scientifica Medica

View PDFchevron_right

A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma

Côme Lepage

Clinical Gastroenterology and Hepatology, 2010

View PDFchevron_right

Challenges of advanced hepatocellular carcinoma

Andrea Inghilesi

World Journal of Gastroenterology, 2016

View PDFchevron_right

New advances in hepatocellular carcinoma

Sonia Pascual

World Journal of Hepatology, 2016

View PDFchevron_right

Nationwide Study of 4741 Patients With Non-B Non-C Hepatocellular Carcinoma With Special Reference to the Therapeutic Impact

Masatoshi Kudo

Annals of Surgery, 2014

View PDFchevron_right

Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice

Corrado Ficorella

BioMed Research International, 2014

View PDFchevron_right

Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial

Vincenza Conteduca

The Oncologist, 2012

View PDFchevron_right

Treatment and prognostic factors in patients with hepatocellular carcinoma

A. Martins

Liver International, 2006

View PDFchevron_right

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options

Andreas Koulouris

Journal of Hepatocellular Carcinoma

View PDFchevron_right

Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study

Taku Iida

Journal of Gastroenterology and Hepatology, 2008

View PDFchevron_right

Diagnosis and Treatment of Hepatocellular Carcinoma

Stephen Riordan

Gastroenterology, 2008

View PDFchevron_right

Treatment of hepatocellular carcinoma: beyond international guidelines

angelo sangiovanni

Liver International, 2014

View PDFchevron_right

Introduction to 2023 Chinese expert consensus on the whole-course management of hepatocellular carcinoma

Hepatoma Research

Hepatoma Research, 2024

View PDFchevron_right

European Association for the Study of the Liver Hepatocellular Carcinoma summit 2014: old questions, new (or few) answers?

Rodolfo Sacco

Future Oncology, 2014

View PDFchevron_right

Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma

Ambuj Kumar

World Journal of Hepatology, 2013

View PDFchevron_right

Management strategies for hepatocellular carcinoma: old certainties and new realities

Roberto Tarquini

Clinical and Experimental Medicine, 2015

View PDFchevron_right

Current advances made in the surgical treatment of hepatocellular carcinoma

Shah Naveed

International Surgery Journal, 2015

View PDFchevron_right

Tumor Response and Factors Affecting Survival of Using Sorafenib in Management of Advanced Hepatocellular Carcinoma

Eman Medhat

Biomedical Journal of Scientific & Technical Research, 2021

View PDFchevron_right

The Improvement in 1-Year Survival Rate of Patients with Hepatocellular Carcinoma BCLC Stage A and B after the Implementation of Comprehensive Management

saut nababan

Journal of Gastrointestinal Cancer, 2019

View PDFchevron_right

Optimal management of hepatocellular carcinoma: Challenges and opportunities

Jia-Horng Kao

Journal of Gastroenterology and Hepatology, 2010

View PDFchevron_right

Multidisciplinary approach for HCC patients: hepatology for the oncologists

giancarlo parisi

Annals of Oncology, 2013

View PDFchevron_right

Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index

Nobuo Toda

Advances in Therapy

View PDFchevron_right

HCC: Achieving Complete Response in a Patient After Liver Transplantation, Metastatic Hepatocellular Carcinoma with Sorafenib Treatment and Radiotherapy Continued with Follow-up

Piyush Vyas

Novel Approaches in Cancer Study, 2019

View PDFchevron_right

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients

Franco Capra

2009

View PDFchevron_right

Hepatocellular carcinoma: Surgical perspectives beyond the barcelona clinic liver cancer recommendations

Fabiola Vazquez

View PDFchevron_right

Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000

Takashi Kumada

Cancer, 2004

View PDFchevron_right

Presentation and outcomes of hepatocellular carcinoma patients at a western centre

jm. vignesh

HPB, 2011

View PDFchevron_right

Treatment options in hepatocellular carcinoma today

Pål-Dag Line

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 2011

View PDFchevron_right

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

David Kerr

Annals of Oncology, 2009

View PDFchevron_right

Nonsurgical Management of Advanced Hepatocellular Carcinoma: A Clinical Practice Guideline

Roxanne Cosby

Current Oncology, 2020

View PDFchevron_right

Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment

Erkan Oymacı

Hepatobiliary & Pancreatic Diseases International, 2016

View PDFchevron_right

Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience

Patrizia Zavattari

Gastrointestinal Tumors

View PDFchevron_right

Etiology, natural history and treatment of hepatocellular carcinoma

angelo sangiovanni

Antiviral Research, 2003

View PDFchevron_right

Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages

José Bilbao

Annals of Surgical Oncology, 2011

View PDFchevron_right

Editorial: Interventional therapy of hepatocellular carcinoma

Ivana Vucenik

Frontiers in Molecular Biosciences

View PDFchevron_right